Effect of medication adherence on the risk of cardiovascular events in outpatients with stable coronary artery disease: results of two-year monitoring

Effect of medication adherence on the risk of cardiovascular events in outpatients with stable coronary artery disease: results of two-year monitoring

Introduction. Incidence of inadequate medication adherence to secondary prevention medications among Russian coronary patients is around 50 %, but the question, how this might influence on the risk of unfavorable outcomes, still has no answer.Aim. To determine the effect of medication adherence on t...

Full description

Bibliographic Details
Main Authors:	S. B. Fitilev, A. V. Vozzhaev, L. N. Saakova, I. B. Bondareva, D. A. Kliuev, I. I. Shkrebniova
Format:	Article
Language:	Russian
Published:	Izdatelstvo OKI 2023-04-01
Series:	Качественная клиническая практика
Subjects:	приверженность фармакотерапии стабильная ишемическая болезнь сердца анализ выживаемости
Online Access:	https://www.clinvest.ru/jour/article/view/648

Similar Items

Multivariate analysis of medication adherence among outpatients with stable coronary artery disease
by: S. B. Fitilev, et al.
Published: (2022-02-01)

Effects of Pharmacy Care Program on medication adherence in outpatients with stable coronary artery disease: a randomized controlled study
by: S. B. Fitilev, et al.
Published: (2022-01-01)

Potential barriers towards optimal medication adherence in out-patients with stable coronary artery disease
by: S. B. Fitilev, et al.
Published: (2023-07-01)

Medication adherence in patients with cardiovascular disease: current view of the problem
by: S. B. Fitilev, et al.
Published: (2020-04-01)

The quality of received drug therapy in patients with stable coronary heart disease according to the ALIGN (TherApy in stabLe Coronary Artery dIsease Patients According to Clinical GuideliNes) study
by: E. D. Zharkova, et al.
Published: (2022-10-01)

Novel approaches to the comprehensive assessment of the quality and adherence to pharmacotherapy and its use in cardiovascular patients
by: Yu. V. Lukina, et al.
Published: (2023-02-01)

Stable coronary heart disease treatment: focus on beta-adrenoblockers
by: V. I. Makolkin
Published: (2008-12-01)

Causes of shortness of breath in patients with stable coronary heart disease
by: S. F. Yarmedova, et al.
Published: (2022-10-01)

Possibilities of atorvastatin loading dose using for the prevention of perioperative myocardial damage in patients with stable coronary artery disease
by: A. S. Ragozina, et al.
Published: (2019-11-01)

Nitrates in complex angina management during the age of aggressive coronary atherosclerosis treatment
by: D. M. Aronov, et al.
Published: (2005-10-01)

PREDICTION OF THE INFLUENCE OF ORIGINAL AND GENERIC ROSUVASTATIN ON DIRECT MEDICAL COSTS OF SECONDARY PREVENTION IN PATIENTS WITH CHRONIC TYPES OF ISCHEMIC HEART DISEASE
by: E. I. Tarlovskaya, et al.
Published: (2015-08-01)

New potential of Trimetazidine MB for coronary heart disease treatment in the real-world clinical practice: results of the Russian multi-centre randomised study PERSPECTIVE (Part II)
by: M. G. Bubnova, et al.
Published: (2011-12-01)

Various protocols of extracorporeal shock wave therapy in the treatment of stable angina
by: M. M. Shcherbak, et al.
Published: (2019-11-01)

Multi-center randomized trial on the impact of “CONFIDENCE” communication program aimed at evaluating therapy adherence of patients with registered myocardial infarction who underwent successful revascularization by stenting or thrombolysis after discharg
by: А. Р. Таркова, et al.
Published: (2017-04-01)

Importance of early diagnostics of chronic obstructive pulmonary disease in patients with coronary heart disease
by: A. N. Kuznetsov, et al.
Published: (2011-06-01)

Lipid-lowering therapy in outpatients of different ages with coronary artery disease
by: S. K. Zyryanov, et al.
Published: (2020-11-01)

Eurasian Guidelines for the diagnostics and management of stable coronary artery disease (2020-2021)
by: Yu. A. Karpov, et al.
Published: (2021-09-01)

LIFE QUALITY ASSESSMENT OF PATIENTS WITH STABLE CORONARY ARTERY DISEASE AFTER MYOCARDIAL REVASCULARIZATION
by: I. A. Narkevich, et al.
Published: (2021-05-01)

EVALUATION OF RANOLAZINE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC STABLE ANGINA. RESULTS FROM THE TERISA RANDOMIZED CLINICAL TRIAL (TYPE 2 DIABETES EVALUATION OF RANOLAZINE IN SUBJECTS WITH CHRONIC STABLE ANGINA)
Published: (2015-09-01)

Clinico-angiographic parallels in patients with coronary atherosclerosis risk factors
by: A. I. Koryakov
Published: (2006-06-01)

Predictors of long term adverse events after scheduled endovascular coronary interventions
by: E. O. Vershinina, et al.
Published: (2018-08-01)

MODELING OF THE 10-YEAR SURVIVAL OF MEN 60 YEARS AND OLDER, WITH ISCHEMIC HEART DISEASE
by: I. V. Tancyreva, et al.
Published: (2015-08-01)

Arterial hypertension and coronary heart disease treatment compliance – a key factor in cardiovascular mortality reduction
by: G. V. Pogosova, et al.
Published: (2007-02-01)

HIGH SELECTIVE LONG-ACTING Β1-BLOCKER WITH A VASODILATING EFFECT NEBIVOLOL IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE
by: V. P. Lupanov
Published: (2015-12-01)

Cardiovascular risk stratification in stable coronary artery disease based on prognostic scores and models
by: S. N. Tolpygina, et al.
Published: (2020-07-01)

Trimetazidine MR effects on heart remodeling in stable coronary heart disease patients
by: E. M. Khurs, et al.
Published: (2007-02-01)

ENDOTHELIAL DYSFUNCTION IN STABLE ANGINA AND MYOCARDIAL INFARCTION COMBINED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: M. A. Popova, et al.
Published: (2015-12-01)

THE PROBLEM OF THE OPTIMAL PHARMACOTHERAPY CHOICE IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE
by: S. R. Gilyarevskiy, et al.
Published: (2015-12-01)

Effectiveness of lipid-lowering therapy in outpatients with coronary artery disease living in a large industrial center of Eastern Siberia
by: N. G. Gogolashvili, et al.
Published: (2022-01-01)

COMPLEX APPROACHES TO TREATMENT OF DYSLIPIDEMIA IN PATIENTS WITH ISHEMIC HEART DISEASE
by: M. A. Chichkova, et al.
Published: (2015-10-01)

Zofenopril in the treatment of patients with arterial hypertension and stable coronary heart disease: effects on oxidative stress and flowdependent vasodilatation
by: F. T. Ageev, et al.
Published: (2011-06-01)

Lipid-lowering therapy in patients with coronary artery disease in primary care practices: what has changed over 7 years?
by: S. K. Zyryanov, et al.
Published: (2020-09-01)

EVALUATION OF MYOCARDIAL REVASCULARIZATION IN STABLE CORONARY HEART DISEASE PATIENTS AND FACTORS ASSOCIATED WITH INVASIVE STRATEGY CHOICE
by: A. S. Korotin, et al.
Published: (2017-08-01)

СИСТЕМНЫЙ АНАЛИЗ В СОВРЕМЕННОЙ МЕТОДОЛОГИИ
by: В. С. Хазов
Published: (2012-10-01)

Stents in coronary heart disease patients: review of the studies available
by: L. A. Bokeriya, et al.
Published: (2009-02-01)

Результаты исследования EUROPA
Published: (2018-06-01)

HYPOLIPIDEMIC THERAPY IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN 2004-2010 ACCORDING TO THE PROGNOZ IBS REGISTER
by: S. N. Tolpygina, et al.
Published: (2015-09-01)

Relevant problems of participation and education of patients in cardiac rehabilitation and secondary prevention programs
by: M. G. Bubnova
Published: (2020-12-01)

Hyperhomocysteinemia and lipid peroxidation in stable coronary heart disease
by: O. L. Belaya, et al.
Published: (2007-02-01)

Secondary prevention of coronary heart disease in Moscow-population patients with myocardial infarction
by: R. G. Oganov, et al.
Published: (2005-06-01)